跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EUG-FLUCLOXACILLIN flucloxacillin (as sodium) 2000 mg powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
EUG-FLUCLOXACILLIN flucloxacillin (as sodium) 2000 mg powder for injection vial
Approved
STANDARD
EUG-FLUCLOXACILLIN flucloxacillin (as sodium) 2000 mg powder for injection vial
Eugia Pharma (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 31, 2025
Approval ID
6e84a77035c9b254
Company
Eugia Pharma (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
6e84a77035c9b254
Product Name
EUG-FLUCLOXACILLIN flucloxacillin (as sodium) 2000 mg powder for injection vial
Artg Id
414665
Artg Name
EUG-FLUCLOXACILLIN flucloxacillin (as sodium) 2000 mg powder for injection vial
Sponsor
Eugia Pharma (Australia) Pty Ltd
Company Detail Path
/organization/eugia-pharma-australia-pty-ltd
Artg Date
2024-09-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 31, 2025
Approval ID
6e84a77035c9b254
Type
Standard
Back to TGA Approvals
